S-1 induced hepatic steatosis in patients with pancreatic cancer: Retrospective analysis

Table 1 Demographic and clinical characteristics of patients with pancreatic cancer receiving S-1 treatment

	Number of patients (n = 22)
Age (yr), median (range)	68 (48-85)
Sex
Male	9
Female	13
Body mass index (kg/m2) median (range)	21 (18-27)
ECOG PS
0	15
1	5
2	2
Drinking habit
Yes	6
No	16
Diabetes mellitus
Yes	6
No	16
Disease status
Locally advanced	14
Metastatic	8
Liver metastasis
Yes	5
No	17
Biliary drainage
Yes	7
No	15
Combination with radiotherapy
Yes	12
No	10
Alanine transaminase concentration (U/L), median (range)	21 (8-73)